Unique molecular identifier

New England Biolabs®, Inc., Announces the NEBNext® Immune Sequencing Kits (Human and Mouse) for Sequencing-based Profiling of T- and B-Cell-mediated Immune Responses

Retrieved on: 
Thursday, August 19, 2021

The kits' streamlined workflows and flexibility make them particularly useful for studies investigating the human immune response to infection and autoimmunity.

Key Points: 
  • The kits' streamlined workflows and flexibility make them particularly useful for studies investigating the human immune response to infection and autoimmunity.
  • The NEBNext Immune Sequencing Kits directly serve the translational research market and include a bioinformatic workflow on the Galaxy platform, based on the open-source pRESTO toolkit.
  • Several publications from his lab demonstrated the use of the NEBNext Immune Sequencing Kit (Human) for these translational research studies.
  • The full product description and ordering details for the NEBNext Immune Sequencing Kit (Human) and NEBNext Immune Sequencing Kit (Mouse) can be found at www.neb.com/E6320 and www.neb.com/E6330 respectively.

Universal Sequencing Technology Launches the TELL-Seq™ WGS Library Prep Kit for Long-Read DNA Sequencing

Retrieved on: 
Thursday, November 21, 2019

CANTON, Mass., Nov. 21, 2019 /PRNewswire-PRWeb/ --Universal Sequencing Technology Corporation ('UST'), a developer of Next Generation Sequencing (NGS) technologies, today emerges from stealth mode, unveiling its TELL-Seq technology for linked, long-read DNA sequencing applications.

Key Points: 
  • CANTON, Mass., Nov. 21, 2019 /PRNewswire-PRWeb/ --Universal Sequencing Technology Corporation ('UST'), a developer of Next Generation Sequencing (NGS) technologies, today emerges from stealth mode, unveiling its TELL-Seq technology for linked, long-read DNA sequencing applications.
  • The TELL-Seq WGS Library Preparation kit tags segments of DNA through molecular barcoding, maintaining the original structure, i.e.
  • Universal Sequencing Technology was founded by next generation DNA sequencing veterans from Roche/454 and is rapidly building out their R&D, operations and commercial teams.
  • Currently, UST has filed a total of 19 patent applications covering linked, long-read library preparation chemistry and groundbreaking 3rd generation DNA sequencing technology.